BackKraneShares Trust - KraneShares Emerging Markets Healthcare Index ETF Overview
KraneShares Trust - KraneShares Emerging Markets Healthcare Index ETF

KraneShares Trust - KraneShares Emerging Markets Healthcare Index ETF Return on Equity

Latest ROE for KraneShares Trust - KraneShares Emerging Markets Healthcare Index ETF: 2.93% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

2.93%

Return on Equity

2.93%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

KraneShares Trust - KraneShares Emerging Markets Healthcare Index ETF (KMED) FAQ

The latest ROE for KMED is 2.93%. That is below the sector sector average of 11.67%. Investors often review this figure alongside KraneShares Trust - KraneShares Emerging Markets Healthcare Index ETF's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, KMED currently prints 2.93% for ROE, while the sector average sits near 11.67%. That is roughly 74.8% below the sector mean. Large gaps often invite a closer look at KraneShares Trust - KraneShares Emerging Markets Healthcare Index ETF's growth, margins, and balance sheet.

Return on Equity shows how effectively KraneShares Trust - KraneShares Emerging Markets Healthcare Index ETF converts resources into returns. At 2.93%, KMED may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting KMED's ROE (2.93%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.